Table 2 Characteristics of the CSF samples from MS patients
Donor | Type | Gender | Age | Disease duration (month) | Treatment before CSF | CSF (cells/μL) | Total Protein CSF (mg/L) | IgG index | Oligoclonal band | Clinical disease activity | MRI Gd enhancement |
|---|---|---|---|---|---|---|---|---|---|---|---|
P-1 | CIS | F | 19 | 0 | – | 2 | 233 | 0.50 | + | + | − |
P-2 | RRMS | F | 25 | 10 | – | 6 | 470 | 0.64 | + | − | − |
P-3 | RRMS | F | 33 | 2 | – | 7 | 338 | 1.96 | + | + | + |
P-4 | RRMS | M | 50 | 34 | – | 3 | 486 | 0.98 | + | − | + |
P-5 | RRMS | M | 22 | 13 | – | 7 | 263 | 0.52 | + | + | + |